Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PEComa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)WithdrawnNCT01690871
What this trial is testing

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Who this might be right for
Malignant PEComa (Perivascular Epithelioid Cell Tumors)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableLooking for participantsNCT01484236
What this trial is testing

National Lymphangioleiomyomatosis Registry, France

Who this might be right for
Lymphangioleiomyomatosis
Vincent COTTIN 200
Not applicableStudy completedNCT03477149
What this trial is testing

EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications

Who this might be right for
VaricoceleEndoleakPortal Vein Thrombosis+2 more
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT00552955
What this trial is testing

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

Who this might be right for
LymphangioleiomyomasTuberous SclerosisLymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableLooking for participantsNCT06405997
What this trial is testing

The Genotype and Phenotype of Lymphangioleiomyomatosis

Who this might be right for
Sporadic LymphangioleiomyomatosisTSC-associated Lymphangioleiomyomatosis
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03253913
What this trial is testing

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 25
Testing effectiveness (Phase 2)Looking for participantsNCT07467772
What this trial is testing

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Who this might be right for
Uterine SarcomaUterine LeiomyosarcomaEndometrial Stromal Sarcoma+6 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT01059318
What this trial is testing

Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Novartis Pharmaceuticals 24
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Early research (Phase 1)Looking for participantsNCT06889168
What this trial is testing

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis
Columbia University 20
Not applicableLooking for participantsNCT06160310
What this trial is testing

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Who this might be right for
Tuberous Sclerosis ComplexLymphangioleiomyomatosis
David M. Ritter 300
Post-approval studies (Phase 4)Study completedNCT01217125
What this trial is testing

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Who this might be right for
Angiomyolipoma
Fundacio Puigvert 18
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Next Page